Abeona Therapeutics (ABEO) Notes Payables (2014)
Abeona Therapeutics (ABEO) recorded quarterly Notes Payables of $400000.0 in Q4 2014, up 60.0% quarter-over-quarter from $250000.0 in Q3 2014.
Abeona Therapeutics (ABEO) Notes Payables (2014) Analysis & Trends
Abeona Therapeutics' Notes Payables history runs 1 years deep, the most recent figure standing at $400000.0 for Q4 2014.
- In Q4 2014, Notes Payables changed N/A year-over-year to $400000.0; the TTM figure through Dec 2014 stood at $400000.0 (changed N/A YoY), while the FY2014 annual figure was $400000.0, changed N/A from the prior year.
- Notes Payables was $400000.0 for Q4 2014 at Abeona Therapeutics, up from $250000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $400000.0 in Q4 2014 to a low of $250000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 400,000.00 |
| Sep 30, 2014 | 250,000.00 |